Background illustration for clinical trials search

Paid Clinical Trials Montreal

Discover 1,169 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

for
Triple Negative Breast Neoplasms
Location: Montreal, Quebec, Chicoutimi, Oshawa, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06841354

Phase 3, Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Montreal, Boston MA, Providence RI, Toronto,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase 2, Phase 3, Recruiting
Active & Responsive

Cannabis Use Patterns Among Young Adults and Associations With Social and Health Outcomes.

for
Cannabis Use
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18 - 24

Code: NCT07063589

Recruiting
Active & Responsive

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

for
Metastatic Non-small Cell Lung Cancer
Location: Montreal, Ottawa, Rochester NY, Toronto, The Bronx NY,
Sponsor: NovoCure GmbH

Sex: All

Age: 18+

Code: NCT06216301

Phase 3, Recruiting
Active & Responsive

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

for
Non-small Cell Lung Cancer
Location: Montreal, Ottawa, Kingston, Albany NY, Syracuse NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07513376

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

for
Malignant Neoplasm
Location: Montreal, Quebec, Toronto, New Brunswick NJ, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07247110

Phase 1, Recruiting
Active & Responsive

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis
Location: Montreal, Trois-Rivieres, Quebec, Ajax, Toronto,
Sponsor: Contineum Therapeutics

Sex: All

Age: 40+

Code: NCT07284459

Phase 2, Recruiting
Active & Responsive

Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository

for
Hypertrophic Cardiomyopathy,
Location: Montreal, Ottawa, Quebec, Hamilton, London, Halifax,
Sponsor: Montreal Heart Institute

Sex: All

Age: 0+

Code: NCT05100420

Recruiting
Active & Responsive

Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, Immunotherapy, Neoadjuvant Therapy
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT06743581

Recruiting
Active & Responsive

Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)

for
Breast Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: Female

Age: 18+

Code: NCT06222788

Recruiting
Active & Responsive

Clinical Course Of Disease In Participants With FA-CM

for
Friedreich Ataxia, Cardiomyopathy
Location: Montreal, Boston MA, Cincinnati OH, Indianapolis IN,
Sponsor: Lexeo Therapeutics

Sex: All

Age: 6+

Code: NCT06865482

Recruiting
Active & Responsive

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Montreal, Providence RI, Toronto, New York NY, London,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06233461

Phase 2, Recruiting
Active & Responsive

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

for
Colorectal Cancer, Pancreatic Ductal Adenocarcinoma,
Location: Montreal, Ottawa, Mineola NY, New York NY, Roanoke VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06428409

Phase 1, Phase 2, Recruiting
Active & ResponsiveNew

Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss

for
Class I/II Obesity
Location: Montreal
Sponsor: Alain Dagher

Sex: All

Age: 35 - 55

Code: NCT07592546

Phase 4, Recruiting
Active & Responsive

Improving Neurological Health With Acetylcholine Via Neuroplasticity-based Computerized Exercise in Mild Cognitive Impairment

for
Mild Cognitive Impairment
Location: Montreal
Sponsor: Posit Science Corporation

Sex: All

Age: 65+

Code: NCT07243600

Recruiting
Active & Responsive

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

for
Myotonic Dystrophy 1
Location: Montreal, Ottawa, Chicoutimi, Calgary
Sponsor: PepGen Inc

Sex: All

Age: 16 - 65

Code: NCT06667453

Phase 2, Recruiting
Active & Responsive

Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

for
Long COVID
Location: Montreal, Sherbrooke, San Diego CA
Sponsor: Douglas D. Fraser

Sex: All

Age: 18 - 65

Code: NCT06928272

Phase 3, Recruiting
Active & Responsive

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

for
Diabetic Nephropathies, Kidney Failure, Chronic,
Location: Montreal, Syracuse NY, Boston MA, Toronto, The Bronx NY,
Sponsor: Alessandro Doria

Sex: All

Age: 18 - 70+

Code: NCT06217302

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

for
Obesity or Overweight, Weight-Related Comorbidity,
Location: Montreal, Joliette, Stouffville, Hamilton, Guelph,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07776509

Phase 3, Recruiting
Active & Responsive

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

for
Non-segmental Vitiligo
Location: Quebec, Newmarket, The Bronx NY, Mississauga, Toronto,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07431177

Phase 2, Recruiting